US-based leading speciality chemicals firm Gabriel Performance Products has acquired a selected portfolio of alkyd resins from Deltech Resin.
Terms of the transaction were not disclosed. The acquisition included a subset of Deltech’s alkyd resin product line, which will now be manufactured at Gabriel’s facility in Harrison City, Pennsylvania.
At the Harrison City facility, Gabriel currently produces Ranbar alkyd resin technology.
Deltech manufactures speciality alkyds and other products for the coatings market. The company expects no changes to its facility in New Cumberland, West Virginia.
Gabriel manufactures a line of speciality proprietary products focused on CASE and custom-developed chemicals using complex chemistries and processes.
The company has been expanding its product line through recent acquisitions. The Deltech transaction is Gabriel’s fifth acquisition since 2014.
Gabriel’s recent agreements include its 2017 acquisition of Ranbar Electrical Materials, a custom manufacturer of speciality resins, varnishes and coatings materials.
In April 2018, Gabriel acquired Royce International, a custom solutions provider of speciality epoxy resins, diluents, curing agents, and additives.
Serving speciality chemical markets with scalable, customised solutions since 1955, Gabriel was acquired by Audax Private Equity in 2014 and has since focused on extending its product portfolio, manufacturing capabilities and solutions to better serve more than 1,000 customers worldwide.
Last November, Gabriel launched a new brand messaging platform and website to help communicate its product and service offerings to its customer base.
Source: Chemicals Technology
Lin will become the company’s Chief Transformation and Talent Officer. She will be responsible for Human Resources, Strategy and Business Consulting and drive the accelerated transformation of Bayer.
Johnson Matthey plc (JM; London) has confirmed that its battery cathode materials plant in Konin, Poland, will be powered solely by electricity from renewable sources from day one of production.
Britain’s Oxford University has received a donation of £100 million (112 million euros, $136 million) to research growing resistance to antibiotics, the university announced on Tuesday. The sum, from British chemicals multinational Ineos, is one of the largest donations given to Oxford University in its long history.